Developer docs
API playgroundTry for free, no card

Search company profiles

Vivici

Full company profile

uuid0000bsa

Namestring
Vivici
Legal namestring
Vivici B.V.
Websiteurl
vivici.com
Company typeenum
Private
Founded yearint
2023
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOegstgeest, Netherlands
HQ citystring
Oegstgeest
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
precision fermentation, animal-free dairy proteins, beta-lactoglobulin ingredient, lactoferrin production, B2B food ingredients
Industry2 codes
PRIMARYAFAHAJAJ
Precision-Fermentation Dairy Analogues Processing (Animal-Free Whey/Casein Products)
Agriculture & Food Production/Dairy Processing/Dairy Alternatives Processing (Plant-Based “Milk”, Yogurt & Cheese Analogues)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
NAICS code3 codes
  • Dairy Product Manufacturing3115
  • Dairy Product (except Frozen) Manufacturing31151
  • Dry, Condensed, and Evaporated Dairy Product Manufacturing311514
SIC code2 codes
  • Dairy Products2020
  • Food And Kindred Products2000
Product category
Precision Fermentation Dairy Proteins
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Ingredient Sales
TypeTransaction Fee
Description

Vivici sells its Vivitein portfolio of precision-fermented dairy proteins (beta-lactoglobulin and lactoferrin) as ingredients to food, beverage, and nutraceutical manufacturers. Revenue generated through ingredient supply agreements and offtake contracts with commercial partners.

prnewswire.com
2Licensing of Precision Fermentation Technology
TypeLicensing Royalties
Description

Potential future licensing revenue as the company scales production and develops additional dairy protein ingredients beyond BLG and lactoferrin.

dairyreporter.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Infrastructure, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Ingredient pricing for food and beverage manufacturers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Lactoferrin trades at $300-$3,000 per kg; Vivici's precision fermentation addresses historical supply and cost constraints. Specific Vivitein product pricing not publicly disclosed.

dairyreporter.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Vivitein™ BLG
Description

Precision-fermented beta-lactoglobulin protein ingredient for performance nutrition and dairy alternatives.

theglobeandmail.com
+1 more record
Core offering1 text field

Vivici manufactures and sells animal-free dairy protein ingredients (beta-lactoglobulin and lactoferrin) produced via precision fermentation. The company supplies its Vivitein ingredient portfolio to food, beverage, and nutraceutical manufacturers under B2B ingredient supply agreements and offtake contracts. The technology uses genetically programmed microorganisms to create bioidentical dairy proteins without animals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 66% lower carbon footprint vs conventional whey protein
+4 more records
Product overview1 text field

Vivici is a Dutch precision fermentation company that produces animal-free dairy proteins. The company operates a Vivitein™ Ingredient Portfolio consisting of two core precision-fermented protein ingredients: Vivitein™ BLG (beta-lactoglobulin) and Vivitein™ LF (lactoferrin). Both products are produced through precision fermentation technology that creates bioidentical dairy proteins without animals, targeting the active nutrition, performance nutrition, and dairy alternatives markets. Vivici was founded in 2023, backed by DSM-Firmenich and Fonterra, and has secured FDA clearance for US market entry.

Product and service2 records
1Vivitein BLG (Beta-Lactoglobulin)
CategoryPrecision-fermented dairy protein ingredient
Description

A precision-fermented animal-free whey protein ingredient producing beta-lactoglobulin without animals. Offers 25g protein per 100ml serving with 66% lower emissions, 86% less water usage, and 61% less land use compared to conventional whey. Holds self-affirmed GRAS status and non-GMO verification for US market sale. Targeted at food, beverage, and nutraceutical manufacturers for performance nutrition, dairy alternatives, and functional beverage applications.

2Vivitein LF (Lactoferrin)
CategoryPrecision-fermented bioactive protein ingredient
Description

A precision-fermented bioactive lactoferrin protein ingredient targeting health, wellness, and nutraceutical manufacturers. Often referred to as 'pink gold,' it addresses traditional supply and cost constraints of lactoferrin by enabling consistent year-round production at stable prices. Holds self-affirmed GRAS status for use in consumer health and wellness products including immune support, gut health, and functional nutrition applications.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-14
Description

Vivici integrated Enduro Genetics' Enduro Sense technology, achieving a 30% increase in production titers and yields within five months. The technology links target substance production to cell survival, addressing biomanufacturing challenges where only 15-20% of cells naturally become high-producers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-24
Description

Vivici and The EVERY Company are exploring a 4 million-liter alternative protein production facility in the UAE in partnership with ADIO, combining capabilities to scale precision fermentation production for the region.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-23
Description

ADIO partnered with Vivici and The EVERY Company to develop a protein fermentation ecosystem in Abu Dhabi, including a planned 4-million-litre industrial facility with Halal certification. The initiative aims to establish Abu Dhabi as a regional hub for advanced food technologies.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-18
Description

Vivici collaborating with Proeon, Applikon, and Planet B.io on the EGGcellent project funded by South Holland (€1 million) to develop plant-based egg alternative for the bakery industry.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-18
Description

Part of the EGGcellent project consortium on the NIZO Food Innovation Campus, contributing to open-access fermentation facility ecosystem.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Israel/US precision fermentation company producing non-animal dairy proteins. Targets identical B2B ingredient customers as Vivici across whey and casein applications.

TypeDirect peer
Description

UK precision fermentation company making animal-free casein and whey proteins for dairy alternatives. Sells the same B2B ingredient proposition into European and UK manufacturers.

TypeEmerging player
Description

US precision fermentation company producing human-equivalent lactoferrin (Effera). Direct competitor in the lactoferrin ingredient category that Vivitein LF targets.

TypeEmerging player
Description

US fermentation-based protein producer (Fy protein from fungi) supplying food and beverage CPG brands. Adjacent technology platform with overlapping B2B active nutrition customers.

TypeBroad incumbent
Description

New Zealand dairy cooperative and co-founder/investor in Vivici. The incumbent dairy supplier whose traditional whey/lactoferrin business is both being augmented and potentially disintermediated by Vivici.

TypeDirect peer
Description

US-Swiss precision fermentation company producing animal-free dairy proteins (casein/whey). Co-developer with Vivici on the Abu Dhabi 4M-litre facility — nearest direct competitor and joint production partner in the same category.

TypeDirect peer
Description

US precision fermentation pioneer producing animal-free whey protein (beta-lactoglobulin). Competes head-to-head with Vivitein BLG for the same B2B active nutrition and dairy-alternative customers.

TypeDirect peer
Description

Israel-based precision fermentation startup developing animal-free dairy proteins (caseins/whey). Direct technical and commercial competitor to Vivici's Vivitein BLG portfolio.

TypeEmerging player
Description

US precision fermentation startup producing animal-free casein for mozzarella cheese. Competes in the downstream dairy-alternative cheese category that depends on the same whey/casein ingredients Vivici supplies.

TypeBroad incumbent
Description

Global ingredients and nutrition major; co-founder and investor in Vivici while also marketing competing fermentation-derived proteins through its wider portfolio. Comparable on scale and technology adjacency.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vivici

Precision Fermentation Dairy Proteinsvivici.com

Vivici firmographics

Firmographics
Name
Vivici
Legal name
Vivici B.V.
Website
https://vivici.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Vivici industry classification

Industry
Product category
Precision Fermentation Dairy Proteins
NAICS
Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151), Dry, Condensed, and Evaporated Dairy Product Manufacturing (311514)
SIC
Dairy Products (2020), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAHAJAJ
Precision-Fermentation Dairy Analogues Processing (Animal-Free Whey/Casein Products)
Agriculture & Food Production/Dairy Processing/Dairy Alternatives Processing (Plant-Based “Milk”, Yogurt & Cheese Analogues)
SECONDARYAFAJAHAL
Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)

Keywords

  • Precision fermentation
  • Animal-free dairy proteins
  • Beta-lactoglobulin ingredient
  • Lactoferrin production
  • B2B food ingredients

Where Vivici is headquartered

Location

Headquarters

HQ city
Oegstgeest
HQ country
Netherlands
HQ region
Europe

Offices2 records

Markets served

Vivici business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Infrastructure, Personnel, Operations, Marketing or Sales

Revenue model

  1. B2B Ingredient Sales: Vivici sells its Vivitein portfolio of precision-fermented dairy proteins (beta-lactoglobulin and lactoferrin) as ingredients to food, beverage, and nutraceutical manufacturers. Revenue generated through ingredient supply agreements and offtake contracts with commercial partners.
  2. Licensing of Precision Fermentation Technology: Potential future licensing revenue as the company scales production and develops additional dairy protein ingredients beyond BLG and lactoferrin.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIngredient pricing for food and beverage manufacturers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Vivici product offering

Product offering

Core offering

Vivici manufactures and sells animal-free dairy protein ingredients (beta-lactoglobulin and lactoferrin) produced via precision fermentation. The company supplies its Vivitein ingredient portfolio to food, beverage, and nutraceutical manufacturers under B2B ingredient supply agreements and offtake contracts. The technology uses genetically programmed microorganisms to create bioidentical dairy proteins without animals.

Product overview

Vivici is a Dutch precision fermentation company that produces animal-free dairy proteins. The company operates a Vivitein™ Ingredient Portfolio consisting of two core precision-fermented protein ingredients: Vivitein™ BLG (beta-lactoglobulin) and Vivitein™ LF (lactoferrin). Both products are produced through precision fermentation technology that creates bioidentical dairy proteins without animals, targeting the active nutrition, performance nutrition, and dairy alternatives markets. Vivici was founded in 2023, backed by DSM-Firmenich and Fonterra, and has secured FDA clearance for US market entry.

Differentiator

Problem solved

Functional benefit

Brands

  • Vivitein™ BLG: Precision-fermented beta-lactoglobulin protein ingredient for performance nutrition and dairy alternatives.
  • Vivitein™ LF

Products and services

  • Vivitein BLG (Beta-Lactoglobulin) A precision-fermented animal-free whey protein ingredient producing beta-lactoglobulin without animals. Offers 25g protein per 100ml serving with 66% lower emissions, 86% less water usage, and 61% less land use compared to conventional whey. Holds self-affirmed GRAS status and non-GMO verification for US market sale. Targeted at food, beverage, and nutraceutical manufacturers for performance nutrition, dairy alternatives, and functional beverage applications.
  • Vivitein LF (Lactoferrin) A precision-fermented bioactive lactoferrin protein ingredient targeting health, wellness, and nutraceutical manufacturers. Often referred to as 'pink gold,' it addresses traditional supply and cost constraints of lactoferrin by enabling consistent year-round production at stable prices. Holds self-affirmed GRAS status for use in consumer health and wellness products including immune support, gut health, and functional nutrition applications.

Quantifiable outcome

  • 66% lower carbon footprint vs conventional whey protein
  • +4 more outcomes

Companies that use Vivici

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Vivici technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Vivici partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Enduro GeneticscoreTechnology or Integration · 14 April 2026Vivici integrated Enduro Genetics' Enduro Sense technology, achieving a 30% increase in production titers and yields within five months. The technology links target substance production to cell survival, addressing biomanufacturing challenges where only 15-20% of cells naturally become high-producers.
  • The EVERY CompanycoreStrategic or Co-development Partner · 24 October 2025Vivici and The EVERY Company are exploring a 4 million-liter alternative protein production facility in the UAE in partnership with ADIO, combining capabilities to scale precision fermentation production for the region.
  • Abu Dhabi Investment Office (ADIO)coreStrategic or Co-development Partner · 23 October 2025ADIO partnered with Vivici and The EVERY Company to develop a protein fermentation ecosystem in Abu Dhabi, including a planned 4-million-litre industrial facility with Halal certification. The initiative aims to establish Abu Dhabi as a regional hub for advanced food technologies.
  • ProeonminorStrategic or Co-development Partner · 18 April 2025Vivici collaborating with Proeon, Applikon, and Planet B.io on the EGGcellent project funded by South Holland (€1 million) to develop plant-based egg alternative for the bakery industry.
  • Planet B.iominorStrategic or Co-development Partner · 18 April 2025Part of the EGGcellent project consortium on the NIZO Food Innovation Campus, contributing to open-access fermentation facility ecosystem.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Vivici competitors and assessment

Company assessment

Direct peers

  • Remilk: Israel/US precision fermentation company producing non-animal dairy proteins. Targets identical B2B ingredient customers as Vivici across whey and casein applications.
  • Better Dairy: UK precision fermentation company making animal-free casein and whey proteins for dairy alternatives. Sells the same B2B ingredient proposition into European and UK manufacturers.
  • The EVERY Company: US-Swiss precision fermentation company producing animal-free dairy proteins (casein/whey). Co-developer with Vivici on the Abu Dhabi 4M-litre facility — nearest direct competitor and joint production partner in the same category.
  • Perfect Day: US precision fermentation pioneer producing animal-free whey protein (beta-lactoglobulin). Competes head-to-head with Vivitein BLG for the same B2B active nutrition and dairy-alternative customers.
  • Imagindairy: Israel-based precision fermentation startup developing animal-free dairy proteins (caseins/whey). Direct technical and commercial competitor to Vivici's Vivitein BLG portfolio.

Emerging players

  • Helaina: US precision fermentation company producing human-equivalent lactoferrin (Effera). Direct competitor in the lactoferrin ingredient category that Vivitein LF targets.
  • Nature's Fynd: US fermentation-based protein producer (Fy protein from fungi) supplying food and beverage CPG brands. Adjacent technology platform with overlapping B2B active nutrition customers.
  • New Culture: US precision fermentation startup producing animal-free casein for mozzarella cheese. Competes in the downstream dairy-alternative cheese category that depends on the same whey/casein ingredients Vivici supplies.

Broad incumbents

  • Fonterra: New Zealand dairy cooperative and co-founder/investor in Vivici. The incumbent dairy supplier whose traditional whey/lactoferrin business is both being augmented and potentially disintermediated by Vivici.
  • DSM-Firmenich: Global ingredients and nutrition major; co-founder and investor in Vivici while also marketing competing fermentation-derived proteins through its wider portfolio. Comparable on scale and technology adjacency.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Vivici social profiles

Digital presence

Vivici compliance and trust

Trust signal

Compliance4 records

Vivici financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vivici leadership team

Management profile

Number of profiles

Profiles1 record

Vivici funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vivici M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivici

What does Vivici do?

Vivici manufactures and sells animal-free dairy protein ingredients (beta-lactoglobulin and lactoferrin) produced via precision fermentation. The company supplies its Vivitein ingredient portfolio to food, beverage, and nutraceutical manufacturers under B2B ingredient supply agreements and offtake contracts. The technology uses genetically programmed microorganisms to create bioidentical dairy proteins without animals.

Is Vivici a public or private company?

Vivici is a private company. It is classified as venture growth investor backed and is currently operating.

When was Vivici founded?

Vivici was founded in 2023. It employs 11 to 50 people.

Where is Vivici based?

Vivici is headquartered in Oegstgeest, Netherlands, in the Europe region.

How does Vivici make money?

Two revenue lines are on record. B2B Ingredient Sales are the primary driver. The others are licensing of Precision Fermentation Technology.

Who are Vivici's main competitors?

Direct peers on record are Remilk, Better Dairy, The EVERY Company, Perfect Day and Imagindairy. Emerging players are Helaina, Nature's Fynd and New Culture. Broad incumbents are Fonterra and DSM-Firmenich.

Does Vivici have an API?

No public API is recorded for Vivici.

What industry is Vivici in?

Vivici's product category is Precision Fermentation Dairy Proteins. Its primary akta.pro industry code is AFAHAJAJ, Precision-Fermentation Dairy Analogues Processing (Animal-Free Whey/Casein Products), with a secondary code of AFAJAHAL, Specialty & Novel Proteins (Single-Cell Protein, Cell-Cultured/Animal-Free Proteins). Its NAICS code is 3115 and its SIC code is 2020.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
vegconomistAnimal-Free Lactoferrin, Fermented Casein, and Vegan Capsules on the Floor at SupplySide GlobalVivici and Standing Ovation are exhibiting at SupplySide Global in Las Vegas, showcasing animal-free lactoferrin and fermented casein products. Vivici presents four Vivitein-based concepts, including a 200 mg lactoferrin capsule and a gut health drink, while Standing Ovation promotes its Advanced Casein ahead of a US launch in 2026.vegconomistVivici, dsm-firmenich and DAB.bio Test Cell Clumping as a Route to Continuous Precision FermentationSix companies and research institutes formed ECOFERM to test continuous precision fermentation by making microbial cells clump together, keeping them in the bioreactor while product is drawn off. The project will use beta-lactoglobulin, a whey protein, and is funded by TKI Agri & Food. Results are expected to apply to other fermentation-made ingredients.The WeekHow UAE plans to achieve food security by 2051 through precision fermentationThe UAE has set a goal under its National Food Security Strategy 2051 to become the world's most food-secure nation by 2051, addressing its heavy dependence on imported food. The country is investing in precision fermentation technology through partnerships with multiple food-tech companies including Change Foods, Novel Foods Group, Vivici, and The Every Company, with investments totaling nearly $500 million to develop production facilities in Abu Dhabi. Abu Dhabi government bodies including ADIO, ADAFSA, and the QCC are also developing streamlined regulatory frameworks for novel foods including precision fermentation products.YahooPrecision Fermentation Ingredient Supplier Market to Reach USD 21.8 Billion by 2036, Driven by Commercial Scale-Up of Animal-Identical ProteinsFuture Market Insights projects the global precision fermentation ingredient supplier market to grow from USD 4.1 billion in 2026 to USD 21.8 billion by 2036, representing a CAGR of 18.2% and creating an incremental opportunity of USD 17.7 billion. Food manufacturers are increasingly adopting precision-fermented animal-identical proteins including whey, casein, and egg proteins to develop sustainable alternatives to conventional animal-derived ingredients. India is identified as the fastest growing market with a projected 20.8% CAGR, while key companies in the space include Perfect Day, Vivici, Remilk, Imagindairy, The Every Company, Onego Bio, and Verley Food.GlobeNewswirePrecision Fermentation-Derived Biomaterials Market Report 2026ResearchAndMarkets.com published a market report projecting the precision fermentation-derived biomaterials market to grow from $1.72 billion in 2025 to $1.94 billion in 2026 (13% CAGR), reaching $3.2 billion by 2030, driven by demand for sustainable biomaterials and alternative proteins. The report highlights Amyris's acquisition of the RealSweet precision fermentation plant in May 2025 and Vivici's March 2025 launch of animal-free dairy protein Vivitein BLG as examples of market activity. North America dominated the 2025 market while Asia-Pacific is forecast to be the fastest-growing region, with key players including Evonik Industries AG, Novozymes A/S, and Perfect Day Inc.foodnavigator.comThe rise and rise of precision-fermented lactoferrinPrecision fermentation technology is enabling lactoferrin, a protein traditionally extracted from dairy with applications in immunity, gut health, and infant nutrition, to scale into mainstream food and beverage markets as an animal-free alternative. Multiple companies including Vivici, Turtle Tree, All G, and Nestlé are actively investing, forming partnerships, and receiving regulatory approvals to commercialize precision-fermented lactoferrin for segments including women's health, sports nutrition, and next-generation infant formula. The lactoferrin market is forecast to reach $810.11 million by 2034, though consumer acceptance of precision-fermented ingredients remains a challenge to overcome.foodnavigator-usa.comThe rise and rise of precision-fermented lactoferrinPrecision fermentation technology is enabling the scalable, animal-free production of lactoferrin—a protein traditionally extracted from cow's milk at high cost—as multiple companies race to commercialize both bovine and human forms. Key players including Turtle Tree, Vivici, All G, and Nestlé have secured regulatory approvals and strategic partnerships, with the global lactoferrin market projected to reach $810.11 million by 2034. Emerging applications span infant formula, women's health, and sports nutrition, supported by a €12.5 million European Innovation Council grant awarded to Vivici in June 2026.foodnavigator.comThe rise and rise of precision-fermented lactoferrinPrecision fermentation technology is enabling the mainstream production of lactoferrin, a protein with immunity and gut health benefits traditionally sourced from cow's milk, with companies scaling both bovine and human variants through genetically engineered micro-organisms. Key players including Nestlé (partnering with Helaina), Novonesis (partnering with Turtle Tree), and Vivici are driving commercialization, with the lactoferrin market projected to reach $810.11 million by 2034. Vivici received a €12.5 million grant from the European Innovation Council Accelerator Program in June 2026 to scale up production, while Turtle Tree and All G have both secured FDA GRAS 'no questions' status for their bovine lactoferrin products.GreenqueenDutch Alternative Protein Startups Urge Govt to Invest €200M via EU SchemeDutch alternative protein startups coordinated by the Mulder Institute have sent an open letter to the Dutch government urging it to commit at least €200M via the EU's Important Projects of Common European Interest (IPCEI) scheme to scale up alternative protein production. The letter, signed by leaders of Mosa Meat, The Protein Brewery, Vivici, Those Vegan Cowboys, NoPalm Ingredients and other organisations, argues this public investment could unlock a further €400M in private capital while preventing Dutch firms from being overtaken by better-funded competitors in China and the US. The government must decide whether to participate and reserve a national budget before the end of August, after which the EU Commission will finalise project portfolios under the IPCEI Biobased Food and Feed Ingredients stream.Pulse 2.0Vivici Raises €12.5 Million From European Innovation CouncilVivici, a Netherlands-based precision fermentation company focused on dairy protein ingredients, has secured €12.5 million from the European Innovation Council Accelerator Program to scale market access for its Vivitein Ingredient Portfolio and advance further innovation. The company was selected after a rigorous evaluation process including an interview before a jury of investors and entrepreneurs, representing a strong endorsement of its technology and commercial progress. Vivici, founded in 2023, has recently launched Vivitein LF lactoferrin in the U.S. market and commercialized Vivitein BLG beta-lactoglobulin, both made through precision fermentation.